Federal contract receipt
$41,914,902 from Department of Health and Human Services to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN
Signals
Full and openLarge awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75A50123C00037_7505_-NONE-_-NONE-
Signed2024-08-30
PlaceMD
MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN
Total obligated$41,914,902.00
PoP Start
2023-07-31
PoP End
2033-07-29
COMPETED
Awarded on 2024-08-30
Vendor
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Agency
Department of Health and Human Services
Category
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Place
MD
© 2025 Sled AI Inc. All rights reserved.